Scinovex
articleTop 10% cited

The COMS Randomized Trial of Iodine 125 Brachytherapy for Choroidal Melanoma

Archives of Ophthalmology · 2006 · Vol. 124(12) · pp. 1684–1684

Abstract

Estimated mortality rates by baseline characteristics should facilitate counseling of patients who have choroidal melanoma of a size and in a location suitable for enucleation or (125)I brachytherapy and no evidence of metastasis or another malignancy.

Ocular Oncology and TreatmentsGlaucoma and retinal disordersRetinal Diseases and TreatmentsMedicineEnucleationMelanomaBrachytherapyMetastasisOcular MelanomaCause of deathMalignancyRadiation therapySurgery

MeSH terms

BrachytherapyCause of DeathChoroid NeoplasmsFemaleHumansIodine RadioisotopesMaleMelanomaMiddle AgedPrognosisEye EnucleationSurvival Rate
Citations
611
FWCI
10.68
field-weighted impact
References
0
Percentile
99%
vs. same field & year
Citations per year
Cited by
Metastatic disease from uveal melanoma: treatment options and future prospects
British Journal of Ophthalmology · 2016 · 432 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

The COMS Randomized Trial of Iodine 125 Brachytherapy for Choroidal Melanoma · Scinovex